These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6189212)

  • 21. Mechanism of interferon action: synthesis and activity of the interferon-mediated low-molecular-weight oligonucleotide from murine and human cells.
    Eppstein DA; Peterson TC; Samuel CE
    Virology; 1979 Oct; 98(1):9-19. PubMed ID: 483575
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequence-specific 2'5'-oligonucleotides in the molecular dissection of the biological activity of 2-5A.
    Torrence PF; Imai J; Jamoulle JC; Wong A; Lesiak K
    Prog Clin Biol Res; 1985; 202():75-80. PubMed ID: 3832077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activities of 8-substituted 2-5A analogues.
    Nagai K; Yokoyama S; Kawai G; Shuhadlnik RJ; Takaku H
    Nucleic Acids Symp Ser; 1990; (22):13-4. PubMed ID: 2101896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(ADP-ribose) polymerase activity is inhibited by 2',5'-oligoadenylates in mouse L-cells.
    Buonamassa DT; Malanga M; Coccia EM; Romeo G; Affabris E; Farina B; Suzuki H
    FEBS Lett; 1989 Nov; 258(1):163-5. PubMed ID: 2480249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metabolism of oligoadenylates in cell nuclei and regulation of protein ADP-ribosylation].
    Pivazian AD; Vartanian AA; Zhelkovskiĭ AM; Karpeĭskiĭ MIa
    Mol Biol (Mosk); 1986; 20(5):1364-70. PubMed ID: 3773890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationship of analogs of 2-5A determined using the core-cellulose assay for 2-5A-dependent RNase.
    Krause D; Lesiak K; Imai J; Sawai H; Torrence PF; Silverman RH
    Prog Clin Biol Res; 1985; 202():133-9. PubMed ID: 3832069
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of interferon action--the discovery of the pppA2'p5'A2'p5'A receptor.
    Li BL; Liu XY
    Sci Sin B; 1985 Jul; 28(7):697-706. PubMed ID: 2422753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2'5'Oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells.
    Baglioni C; Maroney PA; West DK
    Biochemistry; 1979 May; 18(9):1765-70. PubMed ID: 219884
    [No Abstract]   [Full Text] [Related]  

  • 29. Phosphorylation of 2-5A core 5'-diphosphate to 2-5A in mouse L cell extracts.
    Lesiak K; Torrence PF
    Biochem Biophys Res Commun; 1985 Jan; 126(2):917-21. PubMed ID: 3838472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased turnover of vaccinia virus-specific immediate early RNAs in interferon-treated chick embryo fibroblasts.
    Grün J; Zöller B; Jungwirth C
    Immunobiology; 1987 Sep; 175(3):195-201. PubMed ID: 2445663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.
    Kerr IM; Brown RE
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):256-60. PubMed ID: 272640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the (2'-5') oligoadenylate system by characterization of cells deficient in their response to interferon.
    Panet A; Arad G; Rappoport S; Hochman Y
    Prog Clin Biol Res; 1985; 202():345-50. PubMed ID: 2421313
    [No Abstract]   [Full Text] [Related]  

  • 33. Polyclonal antibody directed against 2-5A-dependent RNase.
    Dieffenbach CW; Krause D; Silverman RH
    Prog Clin Biol Res; 1985; 202():105-14. PubMed ID: 2421296
    [No Abstract]   [Full Text] [Related]  

  • 34. Analytical tools for studying the 2-5A system.
    Luxembourg A; Trujillo M; Laurence L; Samuel D; Nicolas M; Roux D; Cailla H; Marti J
    Prog Clin Biol Res; 1985; 202():123-31. PubMed ID: 3913961
    [No Abstract]   [Full Text] [Related]  

  • 35. Intracellular events in interferon-treated cells.
    Hovanessian AG
    Differentiation; 1979; 15(3):139-51. PubMed ID: 393560
    [No Abstract]   [Full Text] [Related]  

  • 36. Conservation and modification of the pyrimidine-rich reovirus oligonucleotides after infection.
    Carter CA; Lin BY
    Virology; 1979 Mar; 93(2):329-39. PubMed ID: 452410
    [No Abstract]   [Full Text] [Related]  

  • 37. The interaction of recombinant HuIFN-gamma 1 and recombinant HuIFN-alpha 2 on the 2-5A system in two distinct cell types.
    Fish EN; Banerjee K
    Prog Clin Biol Res; 1985; 202():385-90. PubMed ID: 3008171
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased resistance of an interferon-resistant cell subline to the toxic effect of double-stranded RNA.
    Lackovic V; Borecký L
    Acta Virol; 1976 Aug; 20(4):347-8. PubMed ID: 9826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular metabolism of the interferon mediator, 2-5A, using permeabilized cells.
    Luxembourg A
    Biochim Biophys Acta; 1988 Nov; 951(1):175-81. PubMed ID: 3191130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon.
    Whitaker-Dowling P; Youngner JS
    Virology; 1986 Jul; 152(1):50-7. PubMed ID: 2424172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.